Literature DB >> 24316020

Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.

Heather E Lynch1, Shelley M Stewart1, Thomas B Kepler2, Gregory D Sempowski1, S Munir Alam3.   

Abstract

Establishment of humoral immunity against pathogens is dependent on events that occur in the germinal center and the subsequent induction of high-affinity neutralizing antibodies. Quantitative assays that allow monitoring of affinity maturation and duration of antibody responses can provide useful information regarding the efficacy of vaccines and adjuvants. Using an anthrax protective antigen (rPA) and alum model antigen/adjuvant system, we describe a methodology for monitoring antigen-specific serum antibody concentration and avidity by surface plasmon resonance during primary and secondary immune responses. Our analyses showed that following a priming dose in mice, rPA-specific antibody concentration and avidity increases over time and reaches a maximal response in about six weeks, but gradually declines in the absence of antigenic boost. Germinal center reactions were observed early with maximal development achieved during the primary response, which coincided with peak antibody avidity responses to primary immunization. Boosting with antigen resulted in a rapid increase in rPA-specific antibody concentration and five-fold increase in avidity, which was not dependent on sustained GC development. The described methodology couples surface plasmon resonance-based plasma avidity measurements with germinal center analysis and provides a novel way to monitor humoral responses that can play a role in facilitating vaccine and adjuvant development.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Antibody avidity; Germinal centers; Protective antigen (PA); Surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2013        PMID: 24316020      PMCID: PMC4104170          DOI: 10.1016/j.jim.2013.11.026

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  46 in total

1.  Kinetic screening of antibodies from crude hybridoma samples using Biacore.

Authors:  Gabriela A Canziani; Scott Klakamp; David G Myszka
Journal:  Anal Biochem       Date:  2004-02-15       Impact factor: 3.365

Review 2.  Modulating vaccine responses with dendritic cells and Toll-like receptors.

Authors:  Bali Pulendran
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

Review 3.  Cell selection by antigen in the immune response.

Authors:  G W Siskind; B Benacerraf
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

Review 4.  Functional anatomy of germinal centers.

Authors:  P Nieuwenhuis; D Opstelten
Journal:  Am J Anat       Date:  1984-07

5.  Anthrax vaccine: short-term safety experience in humans.

Authors:  P R Pittman; P H Gibbs; T L Cannon; A M Friedlander
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

6.  Analysis of adverse events after anthrax immunization in US Army medical personnel.

Authors:  Glenn M Wasserman; John D Grabenstein; Phillip R Pittman; Mark V Rubertone; Paul P Gibbs; Linda Z Wang; Lance G Golder
Journal:  J Occup Environ Med       Date:  2003-03       Impact factor: 2.162

Review 7.  Anthrax vaccines.

Authors:  A M Friedlander; S L Welkos; B E Ivins
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

8.  Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics.

Authors:  Ari J Fried; Michelle L Altrich; Hongye Liu; John F Halsey; Francisco A Bonilla
Journal:  J Clin Immunol       Date:  2013-02-03       Impact factor: 8.317

9.  Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced.

Authors:  Joseph M Dal Porto; Ann M Haberman; Garnett Kelsoe; Mark J Shlomchik
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

10.  A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.

Authors:  Ralf-Herbert Kneitz; Jörg Schubert; Franz Tollmann; Wolfgang Zens; Klaus Hedman; Benedikt Weissbrich
Journal:  BMC Infect Dis       Date:  2004-09-08       Impact factor: 3.090

View more
  21 in total

1.  Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes.

Authors:  Yaoying Wu; Sean H Kelly; Luis Sanchez-Perez; John H Sampson; Joel H Collier
Journal:  Biomater Sci       Date:  2020-05-26       Impact factor: 6.843

2.  Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period.

Authors:  Paul Spearman; Georgia D Tomaras; David C Montefiori; Ying Huang; Marnie L Elizaga; Guido Ferrari; S Munir Alam; Abby Isaacs; Hasan Ahmed; John Hural; M Juliana McElrath; Laissa Ouedraogo; Michael Pensiero; Chris Butler; Spyros A Kalams; Edgar Turner Overton; Susan W Barnett
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

3.  Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies.

Authors:  Lenka Fialová; Milada Petráčková; Oliver Kuchař
Journal:  J Clin Lab Anal       Date:  2017-01-26       Impact factor: 2.352

4.  Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.

Authors:  S Munir Alam; Kenneth Cronin; Robert Parks; Kara Anasti; Haitao Ding; Eden P Go; Heather Desaire; Amanda Eaton; David Montefiori; Joseph Sodroski; John Kappes; Barton F Haynes; Kevin O Saunders
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

5.  Amino acid starvation enhances vaccine efficacy by augmenting neutralizing antibody production.

Authors:  Sumbul Afroz; Srikanth Battu; Shaikh Matin; Sabrina Solouki; Jessica P Elmore; Gillipsie Minhas; Weishan Huang; Avery August; Nooruddin Khan
Journal:  Sci Signal       Date:  2019-11-12       Impact factor: 8.192

6.  Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge.

Authors:  Barbara K Felber; Zhongyan Lu; Xintao Hu; Antonio Valentin; Margherita Rosati; Christopher A L Remmel; Joshua A Weiner; Margaret C Carpenter; Katelyn Faircloth; Sherry Stanfield-Oakley; Wilton B Williams; Xiaoying Shen; Georgia D Tomaras; Celia C LaBranche; David Montefiori; Hung V Trinh; Mangala Rao; Munir S Alam; Nathan A Vandergrift; Kevin O Saunders; Yunfei Wang; Wes Rountree; Jishnu Das; Galit Alter; Steven G Reed; Pyone P Aye; Faith Schiro; Bapi Pahar; Jason P Dufour; Ronald S Veazey; Preston A Marx; David J Venzon; George M Shaw; Guido Ferrari; Margaret E Ackerman; Barton F Haynes; George N Pavlakis
Journal:  Cell Rep       Date:  2020-05-12       Impact factor: 9.423

7.  3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates.

Authors:  Sudhir Pai Kasturi; Mohammed Ata Ur Rasheed; Colin Havenar-Daughton; Mathew Pham; Traci Legere; Zarpheen Jinnah Sher; Yevgeny Kovalenkov; Sanjeev Gumber; Jessica Y Huang; Raphael Gottardo; William Fulp; Alicia Sato; Sheetal Sawant; Sherry Stanfield-Oakley; Nicole Yates; Celia LaBranche; S Munir Alam; Georgia Tomaras; Guido Ferrari; David Montefiori; Jens Wrammert; Francois Villinger; Mark Tomai; John Vasilakos; Christopher B Fox; Steven G Reed; Barton F Haynes; Shane Crotty; Rafi Ahmed; Bali Pulendran
Journal:  Sci Immunol       Date:  2020-06-19

8.  Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes.

Authors:  Hui-Ting Chan; Yuhong Xiao; William C Weldon; Steven M Oberste; Konstantin Chumakov; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2016-06-01       Impact factor: 9.803

9.  Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™.

Authors:  Quentin Canelle; Walthère Dewé; Bruce L Innis; Robbert van der Most
Journal:  Hum Vaccin Immunother       Date:  2016-04-22       Impact factor: 3.452

Review 10.  Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.

Authors:  Elke S Bergmann-Leitner; Wolfgang W Leitner
Journal:  Vaccines (Basel)       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.